Regenerative medicine company Orthocell Ltd (ASX:OCC, OTC:ORHHF) will release its quarterly results for the period ended June ...

The S&P/ASX Small Ordinaries Index (ASX) edged higher, adding 10.70 points, or 0.31%, to 3,407.70 yesterday. Despite the ...

Management “couldn’t be happier” with the early US rollout of its flagship device, Remplir Revenue should start slowly but then escalate rapidly in ‘hockey stick’ style Following Remplir’s surprise ...

Orthocell Ltd (ASX: OCC) share price is catching the eye of investors on Monday. In late afternoon trade, the regenerative medicine company's shares are up over 10% to $1.37. This means that Orthocell ...

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has secured a significant expansion of its US market opportunity, gaining approval for its Remplir nerve repair device to be used across the US Department of Defense ...

Orthocell Ltd (ASX:OCC, OTC:ORHHF) has confirmed it received a $3.0 million refund under the Australian Federal Government’s Research and Development (R&D) Tax Incentive for the financial year ended ...

Perth-based regenerative medicine company Orthocell is expanding the humanitarian reach of its flagship nerve repair product ...

Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks Orthocell Ltd is gearing up for a ...

Regenerative medicine company Orthocell Limited is pleased to announce it will present new positive two year data from a study of its tendon cell treatment for degenerate hip (gluteal) tendons at the ...

When you buy shares in a company, there is always a risk that the price drops to zero. But when you pick a company that is really flourishing, you can make more than 100%. Take, for example Orthocell ...

Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Orthocell Ltd ( (AU ...

Orthocell receives approval for Remplir™ to be used across the United States Department of Defence (DoD) and Veterans Affairs (VA) hospital networks, comprising: For context, Orthocell has already ...